Xavier Thomas

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

Céline Berthon, Emmanuel Raffoux, Xavier Thomas et al. · The Lancet Haematology · 2016 · 431 citations

Medicine, Hematology, Pharmacology +7

Acute lymphoblastic leukemia in the elderly: The Edouard Herriot hospital experience

Xavier Thomas, Nicoleta Olteanu, C Charrin et al. · American Journal of Hematology · 2001 · 78 citations

Medicine, Hematology, Oncology +17

Early detection of <i>WT1</i> measurable residual disease identifies high-risk patients, independent of transplantation in AML

Juliette Lambert, Jérôme Lambert, Xavier Thomas et al. · Blood Advances · 2021 · 27 citations · Full text

Medicine, Hematology, Oncology +15

Healthcare burden and reimbursement of hospitalization during chemotherapy for adults with Ph-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in France: a retrospective chart review

Hervé Dombret, Xavier Thomas, Patrice Chevallier et al. · Journal of Medical Economics · 2016 · 17 citations

Medicine, Hematology, Oncology +16

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Etienne Paubelle, Sophie Ducastelle-Leprêtre, Hélène Labussière‐Wallet et al. · Annals of Hematology · 2016 · 10 citations

Medicine, Oncology, Pharmacology +13